Topic - Mark Roithmayr

Roithmayr said the Lauder family wants to accelerate the timeline for when research will yield treatments by making investments where pharmaceutical companies and the federal government are not.

Lauder family pledges $200M to its Alzheimer's Drug Discovery Foundation →

More autism reported, likely from better testing →